256 related articles for article (PubMed ID: 36510647)
1. Increased incidence of Graves' disease during the SARS-CoV2 pandemic.
Barajas Galindo DE; Ramos Bachiller B; González Roza L; García Ruiz de Morales JM; Sánchez Lasheras F; González Arnáiz E; Ariadel Cobo D; Ballesteros Pomar MD; Rodríguez IC
Clin Endocrinol (Oxf); 2023 May; 98(5):730-737. PubMed ID: 36510647
[TBL] [Abstract][Full Text] [Related]
2. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.
Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB
Front Public Health; 2021; 9():778964. PubMed ID: 34888290
[No Abstract] [Full Text] [Related]
3. Thyroid Inconveniences With Vaccination Against SARS-CoV-2: The Size of the Matter. A Systematic Review.
Caironi V; Pitoia F; Trimboli P
Front Endocrinol (Lausanne); 2022; 13():900964. PubMed ID: 35813627
[TBL] [Abstract][Full Text] [Related]
4. Graves' orbitopathy post-SARS-CoV-2 vaccines: report on six patients.
Abeillon-du Payrat J; Grunenwald S; Gall E; Ladsous M; Raingeard I; Caron P
J Endocrinol Invest; 2023 Mar; 46(3):617-627. PubMed ID: 36378488
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management.
Caron P
Endocrine; 2022 Dec; 78(3):406-417. PubMed ID: 35763241
[TBL] [Abstract][Full Text] [Related]
6. Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence.
Jafarzadeh A; Nemati M; Jafarzadeh S; Nozari P; Mortazavi SMJ
J Endocrinol Invest; 2022 Oct; 45(10):1835-1863. PubMed ID: 35347651
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Vaccine-induced Thyroiditis: Safety of Revaccinations and Clinical Follow-up.
Oğuz SH; Şendur SN; İremli BG; Gürlek A; Erbas T; Ünlütürk U
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1823-e1834. PubMed ID: 35100622
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves' Disease.
Huang L; Jiang Z; Zhou J; Chen Y; Huang H
Front Endocrinol (Lausanne); 2022; 13():835880. PubMed ID: 35651979
[TBL] [Abstract][Full Text] [Related]
9. Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves' disease to silent thyroiditis.
Pujol A; Gómez LA; Gallegos C; Nicolau J; Sanchís P; González-Freire M; López-González ÁA; Dotres K; Masmiquel L
J Endocrinol Invest; 2022 Apr; 45(4):875-882. PubMed ID: 34792795
[TBL] [Abstract][Full Text] [Related]
10. New-onset and relapsed Graves' disease following COVID-19 vaccination: a comprehensive review of reported cases.
Chen K; Gao Y; Li J
Eur J Med Res; 2023 Jul; 28(1):232. PubMed ID: 37443067
[TBL] [Abstract][Full Text] [Related]
11. Relapsed and newly diagnosed Graves' disease due to immunization against COVID-19: A case series and review of the literature.
Bostan H; Ucan B; Kizilgul M; Calapkulu M; Hepsen S; Gul U; Ozturk Unsal I; Cakal E
J Autoimmun; 2022 Apr; 128():102809. PubMed ID: 35220164
[TBL] [Abstract][Full Text] [Related]
12. HLA typing of patients who developed subacute thyroiditis and Graves' disease after SARS-CoV-2 vaccination: a case report.
Yasuda S; Suzuki S; Yanagisawa S; Morita H; Haisa A; Satomura A; Nakajima R; Oikawa Y; Inoue I; Shimada A
BMC Endocr Disord; 2023 Mar; 23(1):54. PubMed ID: 36879263
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 vaccine may trigger thyroid autoimmunity: real-life experience and review of the literature.
Ruggeri RM; Giovanellla L; Campennì A
J Endocrinol Invest; 2022 Dec; 45(12):2283-2289. PubMed ID: 35829989
[TBL] [Abstract][Full Text] [Related]
14. The Incidence of Graves' Hyperthyroidism Before and After COVID-19 Messenger RNA Vaccination.
Endo M; Pinto J; Roth MY; Hoofnagle AN; Failor RA; Tylee TS
Endocr Pract; 2023 Aug; 29(8):618-622. PubMed ID: 37391042
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 mRNA Vaccination and Graves' Disease: A Report of 12 Cases and Review of the Literature.
Chee YJ; Liew H; Hoi WH; Lee Y; Lim B; Chin HX; Lai RTR; Koh Y; Tham M; Seow CJ; Quek ZH; Chen AW; Quek TPL; Tan AWK; Dalan R
J Clin Endocrinol Metab; 2022 May; 107(6):e2324-e2330. PubMed ID: 35235663
[TBL] [Abstract][Full Text] [Related]
16. Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of Graves' disease: An observational cohort study.
Xu S; Yu H; Cheng X; Wu J; Bao J; Zhang L
Vaccine; 2023 Aug; 41(38):5648-5654. PubMed ID: 37544826
[TBL] [Abstract][Full Text] [Related]
17. Thyroid Inflammation and Immunity During the COVID-19 Pandemic: A Comprehensive Review and Case Study.
Lampropoulou E; Benz C; Kahaly GJ; Führer D
Horm Metab Res; 2024 Feb; 56(2):111-117. PubMed ID: 38049146
[TBL] [Abstract][Full Text] [Related]
18. Graves' Disease Following COVID-19 Vaccination: A Population-based, Matched Case-control Study.
Gorshtein A; Turjeman A; Duskin-Bitan H; Leibovici L; Robenshtok E
J Clin Endocrinol Metab; 2024 Jan; 109(2):e508-e512. PubMed ID: 37815523
[TBL] [Abstract][Full Text] [Related]
19. New Onset or Deterioration of Thyroid Eye Disease After mRNA SARS-CoV-2 Vaccines: Report of 2 Cases and Literature Review.
Mohamed A; Tzoulis P; Kossler AL; Dosiou C
J Clin Endocrinol Metab; 2023 Mar; 108(4):979-985. PubMed ID: 36251747
[TBL] [Abstract][Full Text] [Related]
20. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
